Nymox Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2019
March 30, 2020 at 03:38 pm EDT
Nymox Pharmaceutical Corporation announced earnings results for the full year ended December 31, 2019. For the full year, the company announced total revenue was USD 116,000 compared to USD 299,000 a year ago. Operating loss was USD 13.325 million compared to USD 10.641 million a year ago. Net loss was USD 13.162 million compared to USD 10.594 million a year ago. Basic loss per share from continuing operations was USD 0.19 compared to USD 0.18 a year ago.